Prostate Cancer - Results from #100

Efficacy and Safety of Non-Steroidal Anti-Androgens in Patients with Metastatic Prostate Cancer: Meta-Analysis of Randomized Controlled Trials. December 25, 2019

Significant Diagnostic Value of Free-Serum PSA (FPSA)/Prostate-Specific Antigen Density (PSAD) and (F/T)/PSAD for Prostate Cancer of the Chinese Population in a Single Institution. December 25, 2019

Temporal trends and social barriers for inpatient palliative care delivery in metastatic prostate cancer patients receiving critical care therapies. December 25, 2019

PSMA-targeting agents for radio- and fluorescence-guided prostate cancer surgery. December 25, 2019

Tobacco smoking and death from prostate cancer in US veterans. December 25, 2019

Unpacking Trial Offers and Low Accrual Rates: A Qualitative Analysis of Clinic Visits With Physicians and Patients Potentially Eligible for a Prostate Cancer Clinical Trial. December 24, 2019

Post-treatment prostate MRI. December 24, 2019

IMPT versus VMAT for Pelvic Nodal Irradiation in Prostate Cancer: A Dosimetric Comparison. December 24, 2019

Previous, Current, and Future Pharmacotherapy and Diagnosis of Prostate Cancer-A Comprehensive Review. December 24, 2019

Progress in Low Dose Rate Brachytherapy for Prostate Cancer. December 24, 2019

Deep Learning-Based Quantification of PET/CT Prostate Gland Uptake: Association with Overall Survival. December 23, 2019

Effect of external beam radiotherapy on second primary cancer risk after radical prostatectomy. December 23, 2019

Prostate Cancer Diagnosis Using Urine Sediment Analysis-Based α-Methylacyl-CoA Racemase Score: A Single-Center Experience. December 23, 2019

Multiparametric MRI and auto-fixed volume of interest-based radiomics signature for clinically significant peripheral zone prostate cancer. December 23, 2019

Optimal Starting Age and Baseline Level for Repeat Tests: Economic Concerns of PSA Screening for Chinese Men - 10-Year Experience of a Single Center. December 23, 2019

The 68Ga/177Lu-theragnostic concept in PSMA-targeting of metastatic castration-resistant prostate cancer: impact of post-therapeutic whole-body scintigraphy in the follow-up. December 20, 2019

Prospective study to define the clinical utility and benefit of Decipher testing in men following prostatectomy. December 20, 2019

In primary lymph nodal staging of patients with high-risk and intermediate-risk prostate cancer, how critical is the role of Gallium-68 prostate-specific membrane antigen PET computed tomography? December 20, 2019

Impact of 68Ga-PSMA-11 PET staging on clinical decision-making in patients with intermediate or high-risk prostate cancer. December 20, 2019

Open approach, extended pelvic lymph node dissection and seminal vesicle invasion are independent predictors of hospital readmission after prostate cancer surgery: a large retrospective study. December 20, 2019

Page 6 of 1046